These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16720474)

  • 1. Gaucher disease: multiple lessons from a single gene disorder.
    Beutler E
    Acta Paediatr Suppl; 2006 Apr; 95(451):103-9. PubMed ID: 16720474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease: pediatric concerns.
    Elstein D; Abrahamov A; Dweck A; Hadas-Halpern I; Zimran A
    Paediatr Drugs; 2002; 4(7):417-26. PubMed ID: 12083970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gaucher disease: diagnosis and treatment].
    Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K
    Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
    Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
    Yu L; Ikeda K; Kato A; Adachi I; Godin G; Compain P; Martin O; Asano N
    Bioorg Med Chem; 2006 Dec; 14(23):7736-44. PubMed ID: 16919960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
    Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
    Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
    Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
    Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease: from fundamental research to effective therapeutic interventions.
    de Fost M; Aerts JM; Hollak CE
    Neth J Med; 2003 Jan; 61(1):3-8. PubMed ID: 12688562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
    Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease.
    Sawkar AR; D'Haeze W; Kelly JW
    Cell Mol Life Sci; 2006 May; 63(10):1179-92. PubMed ID: 16568247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
    FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease.
    Thirumal Kumar D; Iyer S; Christy JP; Siva R; Tayubi IA; George Priya Doss C; Zayed H
    Adv Protein Chem Struct Biol; 2019; 114():315-339. PubMed ID: 30635084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation prevalence among 51 unrelated Spanish patients with Gaucher disease: identification of 11 novel mutations.
    Alfonso P; Cenarro A; Pérez-Calvo JI; Giralt M; Giraldo P; Pocoví M
    Blood Cells Mol Dis; 2001; 27(5):882-91. PubMed ID: 11783951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.
    Diaz GA; Gelb BD; Risch N; Nygaard TG; Frisch A; Cohen IJ; Miranda CS; Amaral O; Maire I; Poenaru L; Caillaud C; Weizberg M; Mistry P; Desnick RJ
    Am J Hum Genet; 2000 Jun; 66(6):1821-32. PubMed ID: 10777718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: haematological presentations and complications.
    Thomas AS; Mehta A; Hughes DA
    Br J Haematol; 2014 May; 165(4):427-40. PubMed ID: 24588457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).
    Brown JT; Lahey C; Laosinchai-Wolf W; Hadd AG
    BMC Med Genet; 2006 Aug; 7():69. PubMed ID: 16887033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic characteristics of Korean patients with Gaucher disease.
    Jeong SY; Park SJ; Kim HJ
    Blood Cells Mol Dis; 2011 Jan; 46(1):11-4. PubMed ID: 20729108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
    Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
    Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.